.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Harvard Business School
Moodys
Federal Trade Commission
Colorcon
Merck
Deloitte
Healthtrust
Cantor Fitzgerald
Daiichi Sankyo

Generated: November 21, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,544,559

« Back to Dashboard

Summary for Patent: 6,544,559

Title: Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
Abstract:Sustained-release microparticle composition. The microparticle composition can be formulated to provide multi-phasic release. In one aspect, the composition includes microparticles having more than one rate of release. In another aspect, the composition includes microparticles that exhibit diffusional release and microparticles that exhibit biodegradation release.
Inventor(s): Mesens; Jean (Wechelderzande, BE), Rickey; Michael E. (Loveland, OH), Atkins; Thomas J. (York, PA)
Assignee: Alkermes Controlled Therapeutics Inc. II (Cambridge, MA) Janssen Parmaceutica (Beerse, BE)
Application Number:10/058,072
Patent Claim Types:
see list of patent claims
Composition;

No matches for this query

International Patent Family for Patent: 6,544,559

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Chile2004001182► Subscribe
Israel111647► Subscribe
JapanH09505286► Subscribe
Japan3645906► Subscribe
South Korea100354270► Subscribe
HungaryT73501► Subscribe
Germany69434258► Subscribe
Denmark0729357► Subscribe
European Patent Office0729357► Subscribe
Hungary9501942► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Julphar
Queensland Health
McKesson
Harvard Business School
Medtronic
Chubb
US Army
Fuji
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot